Navigation Links
Cardiac Rehab Can Boost Survival After Angioplasty, Study Finds
Date:5/16/2011

MONDAY, May 16 (HealthDay News) -- Patients who undergo angioplasty to unblock a clogged artery have better odds of survival if they participate in a cardiac rehabilitation program afterwards, researchers report.

The findings, published May 16 in Circulation, are significant given the fact that more than 600,000 angioplasties are performed in the United States each year, according to the American Heart Association (AHA).

In the 14-year analysis, researchers examined the outcomes for nearly 2,400 patients who underwent percutaneous coronary interventions (PCI), commonly known as angioplasties. The study found that 44 percent of the patients had participated in at least one session of a cardiac rehabilitation program, which typically includes patient education, customized exercise programs, nutrition counseling, assistance in quitting smoking, weight control therapy and medical evaluations to track patient progress.

Overall, researchers discovered a 46 percent relative reduction in death from all causes in patients who participated in a rehab program following an angioplasty.

"Our findings show that patients who participate in cardiac rehabilitation following [angioplasty] have better long-term survival, about 50 percent better than those who don't participate in cardiac rehabilitation," study author Dr. Randal Thomas, director of the Mayo Clinic's Cardiovascular Health Clinic, said in an AHA news release.

The results took behavioral issues, such as smoking, into account, as well as any medical conditions that might affect life expectancy, including heart failure, kidney disease or diabetes. The researchers also noted a difference in death rates as early as one year after surgery. Improved outcomes were identified across the board, regardless of age or gender.

AHA spokeswoman Dr. Suzanne Steinbaum noted that "cardiac rehabilitation in the past had shown to reduce mortality after a heart attack by 20 to 30 percent," but post-angioplasty rehab programs weren't covered by Medicare until 2006.

"Cardiac rehabilitation provides physiological and psychological benefits of exercise, improves adherence to preventive therapies and manages the cardiovascular risk factors," said Steinbaum, director of women and heart disease at Lenox Hill Hospital in New York City. "In the United States, [the] participation rate is only 25 percent, but clearly as a preventive measure for mortality from heart disease, cardiac rehabilitation as a treatment plan after stent or angioplasty is critical."

The study authors stressed that angioplasty is an important treatment, but not a cure for heart disease. "Cardiac rehabilitation programs are effective at improving recovery, quality of life and long-term survival because they help deliver the lifestyle and medication therapies that have been shown to slow or even reverse the process of heart disease," said Thomas.

More information

The U.S. National Heart, Lung, and Blood Institute provides detailed information on coronary angioplasty.

-- Mary Elizabeth Dallas

SOURCE: Suzanne Steinbaum, M.D., spokeswoman, American Heart Association, and director, women and heart disease, Lenox Hill Hospital, New York City; American Heart Association, news release, May 16, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Pneumonia patients at risk for in-hospital cardiac arrest
2. Gene Variant Linked to Sudden Cardiac Death Risk in Blacks
3. Elevated protein levels in cardiac muscles could predict mortality following angioplasty
4. Genetic defects hold clues to risk for sudden cardiac death
5. Cardiac Arrest Less Deadly in Exercise Facilities, Study Finds
6. Black cardiac arrest patients more likely to be admitted to hospitals with lowest survival rates
7. Penn research using frog embryos leads to new understanding of cardiac development
8. Sudden Cardiac Death More Common in Young Athletes Than Thought
9. Hypothermia proves successful in younger cardiac patients too
10. Free phone app helped doctors perform better in simulated cardiac emergency
11. Canadian Journal of Cardiology publishes advice on genetic testing of inherited cardiac arrhythmias
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cardiac Rehab Can Boost Survival After Angioplasty, Study Finds
(Date:2/22/2017)... ... February 22, 2017 , ... ... newest advanced absorption cannabidiol (CBD) serum, “NANOCALM 300” Microemulsified Hemp Extract. This ... instant absorption from the mouth into the bloodstream. Far outpacing the ...
(Date:2/22/2017)... ... 22, 2017 , ... The Centers for Medicare & Medicaid ... in Delaware, New Jersey, Pennsylvania and West Virginia prepare for and participate in ... Act of 2015 (MACRA). , This technical assistance, authorized and funded under ...
(Date:2/22/2017)... NJ (PRWEB) , ... February 22, 2017 , ... ... healthcare communications company, launched a new media platform connecting healthcare technology professionals and ... will be followed by a quarterly publication starting on March 1, announced Michael ...
(Date:2/22/2017)... ... February 22, 2017 , ... Pet obesity in the U.S. continued ... according to the Association for Pet Obesity Prevention (APOP). During the ninth annual survey, ... such as the benefits of corn and grains, value of raw and organic diets, ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... so many different solutions on the market, it is easy to start feeling ... Premier Locksmith offers a complimentary security consultation. , Home Security Hardware Choices, ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... , Feb. 22, 2017 Henry ... an exclusive distribution agreement with Rijuven, which develops ... diagnostic device to medical practitioners. ... electrocardiogram (ECG) and heart sound signals, transmits real-time ... and offers cloud-based analysis to help physicians provide ...
(Date:2/22/2017)... Calif. , Feb. 22, 2017  Bioness, Inc., ... therapies, today announced the first series of successful StimRouter ... at Radboud University Medical Center (Nijmegen, Netherlands ... ( Cork, Ireland ), and Kliniek Park ... the successful launch continuing, Bioness plans to further support ...
(Date:2/22/2017)... , Feb. 22, 2017 Oncternal Therapeutics, ... for both rare and common malignancies, today announced ... financing. The company intends to use the proceeds ... TK216, and to advance preclinical development of a ... Cirmtuzumab is a first-in-class anti-ROR1 monoclonal antibody being ...
Breaking Medicine Technology: